Literature DB >> 22224834

Default mode network activity and connectivity in psychopathology.

Susan Whitfield-Gabrieli1, Judith M Ford.   

Abstract

Neuropsychiatric disorders are associated with abnormal function of the default mode network (DMN), a distributed network of brain regions more active during rest than during performance of many attention-demanding tasks and characterized by a high degree of functional connectivity (i.e., temporal correlations between brain regions). Functional magnetic resonance imaging studies have revealed that the DMN in the healthy brain is associated with stimulus-independent thought and self-reflection and that greater suppression of the DMN is associated with better performance on attention-demanding tasks. In schizophrenia and depression, the DMN is often found to be hyperactivated and hyperconnected. In schizophrenia this may relate to overly intensive self-reference and impairments in attention and working memory. In depression, DMN hyperactivity may be related to negative rumination. These findings are considered in terms of what is known about psychological functions supported by the DMN, and alteration of the DMN in other neuropsychiatric disorders.

Entities:  

Mesh:

Year:  2012        PMID: 22224834     DOI: 10.1146/annurev-clinpsy-032511-143049

Source DB:  PubMed          Journal:  Annu Rev Clin Psychol        ISSN: 1548-5943            Impact factor:   18.561


  499 in total

1.  Perseverate or decenter? Differential effects of metacognition on the relationship between parasympathetic inflexibility and symptoms of depression in a multi-wave study.

Authors:  Jonathan P Stange; Jessica L Hamilton; David M Fresco; Lauren B Alloy
Journal:  Behav Res Ther       Date:  2017-07-17

2.  Meditation and the Wandering Mind: A Theoretical Framework of Underlying Neurocognitive Mechanisms.

Authors:  Tracy Brandmeyer; Arnaud Delorme
Journal:  Perspect Psychol Sci       Date:  2020-06-29

3.  Static and dynamic characteristics of cerebral blood flow during the resting state in schizophrenia.

Authors:  Jochen Kindler; Kay Jann; Philipp Homan; Martinus Hauf; Sebastian Walther; Werner Strik; Thomas Dierks; Daniela Hubl
Journal:  Schizophr Bull       Date:  2013-12-10       Impact factor: 9.306

4.  The neuroeconomics of alcohol demand: an initial investigation of the neural correlates of alcohol cost-benefit decision making in heavy drinking men.

Authors:  James MacKillop; Michael T Amlung; John Acker; Joshua C Gray; Courtney L Brown; James G Murphy; Lara A Ray; Lawrence H Sweet
Journal:  Neuropsychopharmacology       Date:  2014-03-03       Impact factor: 7.853

Review 5.  Decentering and Related Constructs: A Critical Review and Metacognitive Processes Model.

Authors:  Amit Bernstein; Yuval Hadash; Yael Lichtash; Galia Tanay; Kathrine Shepherd; David M Fresco
Journal:  Perspect Psychol Sci       Date:  2015-09

Review 6.  A neurobehavioral account for decentering as the salve for the distressed mind.

Authors:  Anthony P King; David M Fresco
Journal:  Curr Opin Psychol       Date:  2019-02-22

7.  Functional Brain Networks Underlying Evidence Integration and Delusions in Schizophrenia.

Authors:  Katie M Lavigne; Mahesh Menon; Todd S Woodward
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

8.  Default mode network activity in male adolescents with conduct and substance use disorder.

Authors:  Manish S Dalwani; Jason R Tregellas; Jessica R Andrews-Hanna; Susan K Mikulich-Gilbertson; Kristen M Raymond; Marie T Banich; Thomas J Crowley; Joseph T Sakai
Journal:  Drug Alcohol Depend       Date:  2013-10-24       Impact factor: 4.492

Review 9.  Neuroimaging biomarkers for early drug development in schizophrenia.

Authors:  Jason R Tregellas
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

10.  Increased neural activity during overt and continuous semantic verbal fluency in major depression: mainly a failure to deactivate.

Authors:  Heidelore Backes; Bruno Dietsche; Arne Nagels; Mirjam Stratmann; Carsten Konrad; Tilo Kircher; Axel Krug
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-02-21       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.